1 |
Christian K, Robert S, Daniel C, Rotraut M. Systemic therapies of Pityriasis rubra pilaris: a systematic review. Treatment of Pityriasis rubra pilaris type I: a systematic review Pityriasis rubra pilaris--a retrospective single center analysis over eight years. J Dtsch Dermatol Ges 2019;17(3):243-59.
|
2 |
Jeong JT, Kye YC, Kim SN. A Clinical and Histopathologic Study of Pityriasis rubra pilaris. Ann Dermatol 2002;40(4):363-74.
|
3 |
Sim SY. A Case of Honyoja : Pityriasis rubra pilaris with good response to Korean Medicine. J Korean Med Ophthalmol Otolaryngol Dermatol 2015;28(4):215-20.
DOI
|
4 |
Tarral C Observation CXVIIII In: Rayer P, ed. Traite theorique et pratique des maladies de la peau. Vol 2. Paris: Bailliere; 1835, p. 158-9.
|
5 |
Devergie A. Traite pratique des maladies de la peau. Paris: Masson; 1857, p. 454-64.
|
6 |
Besnier E. Observation pour server a historic clinique du, Pityriasis rubra pilaris. Am Dermatol Syphil 1889;10:253-87.
|
7 |
Griffiths WA. Pityriasis rubra pilaris: the problem of its classification. J Am Acad Dermatol 1992;26(1):140-2.
DOI
|
8 |
Tarral C. General psoriasis-desquamation from the parts covered by hair. In: Rayer P, editor. A theoretical and practical treatise on the diseases of the skin. 2nd ed. London: Baillere 1835, p. 648-9.
|
9 |
Griffiths WA, Judge MR, Leigh IM. Disorders of keratinization-Pityriasis rubra pilaris. In: Champion RH, Burton JL, Burns DA, et al, editors. Text Book of dermatology. 6th ed. London: lackwell Science; 1988, p. 1539-45.
|
10 |
Gold Smith LA, Baden HP. Pityriasis rubra pilaris. In: Freeberg IM, Eisen AZ, Wolff K, et al, editors. Dermatology in general medicine. Vol 1 6th ed. London: Mc-Graw Hill Publication; 2003, p. 442-4.
|
11 |
Bragg J, Witkiewicz A, Orlow SJ, Schaffer JV. Pityriasis rubra pilaris, type IV. Dermatol Online J 2005;11(4):14.
|
12 |
Mortimer PS, Dawber RP. Dermatologic disease of the nail unit other than psoriasis and lichen planus. Dermatol Clin 1985;3(3):401-7.
DOI
|
13 |
Lambert DG, Dalac S. Nail changes in type 5 Pityriasis rubra pilaris. J Am Acad Dermatol 1989;21(4Pt1):811-2.
DOI
|
14 |
Sehgal VN, Srivastav G. (Juvenile) Pityriasis rubra pilaris. Int J Dermatol 2006;45(4):438-46.
DOI
|
15 |
Caldarola G, Zampetti A, De Simone C, Massi G, Amerio P, Feliciani C. Circumscribed Pityriasis rubra pilaris type IV. Clin Exp Dermatol 2007;32(4):471-2.
DOI
|
16 |
Misery I, Faure M, Claidy A. Pityriasis rubra pilaris and human immunodeficiency virus infection-type 6 Pityriasis rubra pilaris? Br J Dermatol 1996;135(6):1008-9.
DOI
|
17 |
Fung PM. Pityriasis rubra pilaris: an Update Review. Hong Kong J Dermatol 2001;9(1):10-6.
|
18 |
Ma JM, Zhang YF. Pityriasis rubra pilaris. Shandong Journal of Traditional Chinese Medicine 1993;13(5):49.
|
19 |
Wang CX. Experience of TCM differentiation and treatment of pityriasis pilaris. Journal of Sichuan Traditional Chinese Medicine 2009;27(5):35.
|
20 |
Yang Z, Cai NN. Current status of TCM treatment of Pityriasis rubra pilaris. JBUTCM 2006;13(6):45-6.
|
21 |
Department of Sasang constitutional medicine, Collage of national Korean medicine. Sasang constitutional medicine(Revised supplement). Seoul: Jipmoondang; 2016, p. 670, 692 710-11, 723
|
22 |
Son JM, Choi IH. A Literature Study about the Correlation between Genetic Studies on Atopic Dermatitis, Sasang Constitution, and Sasang Constitutional Study on Atopic Dermatitis. J Korean Med Ophthalmol Otolaryngol Dermatol 2005;18(2):1-9.
|
23 |
Kim YH, Park YS. Effect of Acanthopanacis cortex Water Extract on Antioxidative Activity, Lipid Profile and Epidermal Thickness in DNCB-induced Allergic Contact Dermatitis Animal Model. Korean J Food Sci Technol 2006;38(5):668-73.
|
24 |
Park HS, Joo JC, Lee EJ. Clinical Practice Guideline for Taeyangin Disease of Sasang Constitutional Medicine. J Sasang Constitut Med 2015;27(1):71-81.
DOI
|
25 |
Song DU, Min GY, Hong SY, Lim SE, Huh J, Sohn YJ, et al. Effects of KMS on the DNCB induced animal Model of Atopic Dermartitis. J Korean Med 2019;40(1):63-77.
|
26 |
Kim YJ, Song CH. Anti-Inflammatory Effect of Bower Actinidia in LPS-Stimulated RAW264.7 Cells. Korean Journal of Acupuncture 2013;30(4):243-51.
DOI
|
27 |
An SM, Kim HG, Choi EJ, Hwang HH, Lee ES, Baek JH, et al. Screening for Anti-inflammatory Activities in Extracts from Korean Herb Medicines. J Soc Cosmet Scientists Korea 2014;40(1):95-108.
DOI
|
28 |
Ryu HW, Kim YS, Lim EM. The Antiinflammatory Effects of Chaenomelis Fructus Herba Water Extract on Mouse RAW 264.7 Cell. J Korean Obstet Gynecol 2012;25(3):1-15.
DOI
|
29 |
Kim HS, Jeon IH, Mok JY, Kang HJ, Jang SI. Antipruritic Effects of Ethanol Extracts from Perillae Japonicae Semen leaves and Chaenomelis Fructus. J Physiol & Pathol Korean Med 2012;26(3):314-9.
|
30 |
Fuchs-Telem D, Sarig O, van Steensel MA, Isakov O, Israeli S, Nousbeck J, et al. Familial Pityriasis rubra pilaris Is Caused by Mutations in CARD14. Am J Hum Genet 2012;91(1):163-70.
DOI
|
31 |
Koch L, Schoffl C, Aberer W, Massone C. Methotrexate treatment for Pityriasis rubra pilaris: a case series and literature review. Acta Derm Venereol 2018;98(5):501-5.
DOI
|
32 |
Parna E, Aluoja A, Kingo K. Quality of life and emotional state in chronic skin disease. Acta Derm Venereol 2015;95(3):312-6.
DOI
|
33 |
Soeprono FF. Histologic criteria for the diagnosis of Pityriasis rubra pilaris. Am J Dermatopathol 1986;8(4):277-83.
DOI
|
34 |
Klein A, Landthaler M, Karrer S. Pityriasis rubra pilaris: a review of diagnosis and treatment. Am J Clin Dermatol 2010;11(3):157-70.
DOI
|
35 |
Eastham AB, Femia AN, Qureshi A, Vleugels RA. Treatment options for Pityriasis rubra pilaris including biologic agents: a retrospective analysis from an academic medical center. JAMA Dermatol 2014;150(1):92-4.
DOI
|
36 |
Gemmeke A, Schonlebe J, Koch A, Wollina U. Pityriasis rubra pilaris - a retrospective single center analysis over eight years. J Dtsch Dermatol Ges 2010;8(6):439-44.
|
37 |
Goldsmith LA, Weinrich AE, Shupack J. Pityriasis rubra pilaris response to 13-cis-retinoic acid (isotretinoin). J Am Acad Dermatol 1982;6(4pt2suppl):710-5.
DOI
|
38 |
Dicken CH. Treatment of classic Pityriasis rubra pilaris. J Am Acad Dermatol 994;31(6):997-9.
DOI
|
39 |
Molin S, Ruzicka T. Treatment of refractory Pityriasis rubra pilaris with oral alitretinoin: case report. Br J Dermatol 2010;163(1):221-3.
DOI
|
40 |
Schmitt L, Inhoff O, Dippel E. Oral alitretinoin for the treatment of recalcitrant Pityriasis rubra pilaris. Case Rep Dermatol 2011;3(1):85-8.
DOI
|
41 |
Amann PM, Susic M, Gluder F, Berger H, Krapf W, Loffler H. Alitretinoin (9-cis retinoic acid) is effective against Pityriasis rubra pilaris: a retrospective clinical study. Acta Derm Venereol 2015;95(3):329-31.
DOI
|
42 |
Pampin A, Gomez-de la Fuente E, Caro Gutierrez MD, Lopez-Estebaranz JL. Successful treatment of atypical adult Pityriasis rubra pilaris with oral alitretinoin. J Am Acad Dermatol 2013;69(2):105-6.
DOI
|
43 |
Kromer C, Sabat R, Celis D, Mossner R. Systemic therapies of Pityriasis rubra pilaris: a systematic review. J Dtsch Dermatol Ges 2019;17(3):243-59.
|
44 |
Moretta G, De Luca EV, Di SA. Management of refractory Pityriasis rubra pilaris: challenges and solutions. Clin Cosmet Investig Dermatol 2017;9(10):451-7.
DOI
|
45 |
Hsu DC, Katelaris CH. Long-term management of patients taking immunosuppressive drugs. Aust Prescr 2009;32(3):68-71.
DOI
|
46 |
Muhammad Y, Amandeep G, Pankaj B, Sidharth S. "Corticosteroid Adverse Effects" July 4, 2020. https://www.ncbi.nlm.nih.gov/books/NBK531462/.
|
47 |
Korean Dermatological Society Textbook Compilation Committee. Text of Dermatology. 6th editon. Seoul: Sungbo Medical booke store; 2014, p.316-8.
|
48 |
Griffiths WA. Pityriasis rubra pilaris. Clin Exp Dermatol 1980;5(1):105-12.
DOI
|
49 |
Klein A, Landthaler M, Karrer S. Pityriasis rubra pilaris: a review of diagnosis and treatment. Am J Clin Dermatol 2010;11(3):157-70.
DOI
|